SUNNYVALE, Calif., Sept. 26 Cepheid(Nasdaq: CPHD) will present at the William Blair & Company Small-Cap GrowthStock Conference on October 3, 2007 at 10:40 a.m. ET at the New York PalaceHotel, New York. John R. Sluis, Cepheid's Chief Financial Officer and Dr.David Persing, Cepheid's Chief Medical and Technology Officer, will provide acorporate overview.
The webcast, along with accompanying presentation slides, may be accessedon Cepheid's Web site at http://www.cepheid.com under Investors: Events:Webcasts and Presentations. A replay of the webcast presentation will beavailable for 90 days.
Cepheid (Nasdaq: CPHD), based in Sunnyvale, California, is a moleculardiagnostics company that develops, manufactures, and markets fully-integratedsystems for genetic analysis in the clinical, industrial and biothreatmarkets. The company's systems enable rapid, sophisticated genetic testing fororganisms and genetic-based diseases by automating otherwise complex manuallaboratory procedures. The company's easy-to-use systems integrate a number ofcomplicated and time-intensive steps, including sample preparation, DNAamplification and detection, which enable the analysis of complex biologicalsamples in its proprietary test cartridges. Through its strong molecularbiology capabilities, the company is focusing on those applications whererapid molecular testing is particularly important, such as identifyinginfectious disease and cancer in the clinical market; food, agricultural, andenvironmental testing in the industrial market; and identifying bio-terrorismagents in the biothreat market. See http://www.cepheid.com for moreinformation.